Alan Davison

19.5k total citations · 2 hit papers
359 papers, 14.7k citations indexed

About

Alan Davison is a scholar working on Organic Chemistry, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan Davison has authored 359 papers receiving a total of 14.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Organic Chemistry, 85 papers in Molecular Biology and 82 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan Davison's work include Radiopharmaceutical Chemistry and Applications (70 papers), Lanthanide and Transition Metal Complexes (43 papers) and Organometallic Complex Synthesis and Catalysis (37 papers). Alan Davison is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (70 papers), Lanthanide and Transition Metal Complexes (43 papers) and Organometallic Complex Synthesis and Catalysis (37 papers). Alan Davison collaborates with scholars based in United Kingdom, United States and Canada. Alan Davison's co-authors include Alun G. Jones, M. L. Cuzner, Pamela White, D. M. Bowen, David M. Bowen, Carolyn Beebe Smith, Neil R. Sims, Naren L. Banik, L. K. Kaczmarek and R. H. Holm and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Alan Davison

356 papers receiving 13.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES

1976 977 citations Alan Davison et al. profile →
Symmetrically disubstituted ferrocenes

1971 366 citations Alan Davison et al. Journal of Organometallic Chemistry profile →

Peers

Countries citing papers authored by Alan Davison

Since Specialization

Citations

This map shows the geographic impact of Alan Davison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Davison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Davison more than expected).

Fields of papers citing papers by Alan Davison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Davison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Davison. The network helps show where Alan Davison may publish in the future.

Co-authorship network of co-authors of Alan Davison

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Davison. A scholar is included among the top collaborators of Alan Davison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Davison. Alan Davison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Uptake of cationic technetium complexes in cultured human carcinoma cells and human xenografts 1998 ·Nuclear Medicine and Biology ·(unknown), James F. Kronauge, Alan Davison, Alun G. Jones	10
2	A new approach to labeling cells with technetium-99m, part II. Evaluation of radiolabeled human-lymphocyte immune functions 1996 ·Nuclear Medicine and Biology ·(unknown), Ashfaq Mahmood, Alan Davison, Alun G. Jones	1
3	A new approach to labeling cells with technetium-99m, part I. Preparation of modified polylysine and in vitro cell labeling 1996 ·Nuclear Medicine and Biology ·Ashfaq Mahmood, (unknown), (unknown), Alan Davison, Alun G. Jones	2
4	Technepine: A high-affinity99mtechnetium probe to label the dopamine transporter in brain by SPECT imaging 1996 ·Synapse ·Bertha K. Madras, Alun G. Jones, Ashfaq Mahmood, R.E. Zimmerman, Basem Garada, (unknown), Alan Davison, Paul Blundell, Peter C. Meltzer	53
5	In vivo metabolism of the technetium isonitrile complex [Tc(2-ethoxy-2-methyl-1-isocyanopropane)6]+ 1994 ·Nuclear Medicine and Biology ·(unknown), James F. Kronauge, Catherine E. Costello, (unknown), B. Leonard Holman, Alan Davison, Alun G. Jones	15
6	Mitochondrial localization and characterization of 99Tc-SESTAMIBI in heart cells by electron probe X-ray microanalysis and 99Tc-NMR spectroscopy 1994 ·Magnetic Resonance Imaging ·David Piwnica-Worms, James F. Kronauge, Ann LeFurgey, (unknown), (unknown), Peter Ingram, (unknown), B. Leonard Holman, Alun G. Jones, Alan Davison	38
7	Isolation and Characterization of Cells Infiltrating the Spinal Cord during the Course of Chronic Relapsing Experimental Allergic Encephalomyelitis in the Biozzi AB/H Mouse 1993 ·Cellular Immunology ·(unknown), David Baker, J.K. O'Neill, Alan Davison, John L. Turk	61
8	The relevance of experimental allergic encephalomyelitis to multiple sclerosis 1992 ·Journal of the Royal Society of Medicine ·Alan Davison	2
9	Comparison of neutral and cationic myocardial perfusion agents: Characteristics of accumulation in cultured cells 1992 ·International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology ·James F. Kronauge, Mark L. Chiu, (unknown), Alan Davison, B. Leonard Holman, Alun G. Jones, David Piwnica‐Worms	22
10	Mechanisms of immune-mediated demyelinating disease of the central nervous system 1991 ·Neurochemical Research ·David Baker, Alan Davison	6
11	Suppression of demyelination by mitoxantrone 1991 ·International Journal of Immunopharmacology ·(unknown), Alan Davison, David Baker, J.K. O'Neill, John L. Turk	50
12	Functional cholesteryl binding agents: Evaluation of viability and specificity of antibodies bound to modified phospholipid vesicles 1988 ·Biochemical and Biophysical Research Communications ·Timothy R. Carroll, Alan Davison, Alun G. Jones	1
13	Nervous and immune system disorders in multiple sclerosis 1988 ·Brain Behavior and Immunity ·Alan Davison, (unknown), S Owen, VL Calder	1
14	Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations 1984 ·International Journal of Nuclear Medicine and Biology ·Alun G. Jones, Michael J. Abrams, Alan Davison, James W. Brodack, (unknown), S. James Adelstein, Amin I. Kassis	155
15	The investigation of radiopharmaceutical components by fast atom bombardment mass spectrometry: the identification of Tc-HIDA and the epimers of Tc-CO2DADS. 1983 ·PubMed ·Catherine E. Costello, James W. Brodack, Alun G. Jones, Alan Davison, (unknown), S. Kasina, Alan R. Fritzberg	15
16	The Suppression of experimental allergic encephalomyelitis and multiple sclerosis 1980 ·Academic Press eBooks ·Alan Davison, M. L. Cuzner, Northern Ireland	25
17	Complex Carbohydrates of Nervous Tissue 1980 ·Biochemical Society Transactions ·Alan Davison	49
18	IMMUNOCHEMISTRY AND BIOCHEMISTRY OF MYELIN 1977 ·British Medical Bulletin ·Alan Davison, M. L. Cuzner	24
19	Fluxonial behavior and isomerization of 1,2-bis(trimethylsilyl)indene: evidence for 1,2-shifts 1970 ·Journal of Organometallic Chemistry ·Alan Davison, P. E. RAKITA	9
20	RELATIVE STABILITY OF BRAIN LIPIDS 1958 ·The Lancet ·Alan Davison, John Dobbing	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact